Barclays PLC Stereotaxis, Inc. Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Barclays PLC holds 113,039 shares of STXS stock, worth $209,122. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,039
Previous 101,953
10.87%
Holding current value
$209,122
Previous $208,000
24.04%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding STXS
# of Institutions
92Shares Held
41.8MCall Options Held
217KPut Options Held
4.1K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$25.3 Million8.48% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.13MShares$7.63 Million5.1% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$6.55 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$6.43 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.79MShares$5.16 Million4.96% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $138M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...